Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (641-650 of 993) with videos related to

Pageof 100
Sort By:
Oncotarget|August 28, 2019
V-ATPase-associated prorenin receptor is upregulated in prostate cancer after PTEN lossAmro H Mohammad, Sarah Assadian, Frédéric Couture, et al.
World Journal of Urology|October 12, 2022
Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicityGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
Journal of Racial and Ethnic Health Disparities|January 9, 2025
Non-Caucasian Race/Ethnicity Predisposes to Unfavorable Stage and Grade at Upper Tract Urothelial Carcinoma DiagnosisFrancesco Di Bello, Mario de Angelis, Carolin Siech, et al.
Annals of Surgical Oncology|October 8, 2024
Perioperative Complications and In-Hospital Mortality in Paraplegic Radical Cystectomy PatientsFrancesco Di Bello, Carolin Siech, Mario de Angelis, et al.
Annals of Surgical Oncology|September 23, 2024
Adult Prostate Sarcoma: Demographics, Treatment Patterns, and SurvivalCarolin Siech, Mario de Angelis, Francesco Di Bello, et al.
The Journal of Urology|November 28, 2022
Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell CarcinomaGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
European Urology|July 13, 2016
Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302Johann S de Bono, Matthew R Smith, Fred Saad, et al.
The Prostate|February 17, 2015
Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North AmericaAnthony M Joshua, Neal D Shore, Fred Saad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2026
131I-LNTH-1095 Radioligand Therapy Plus Enzalutamide vs. Enzalutamide Alone in Men With PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase 2 StudyEvan Y Yu, Vivek Narayan, Giuseppe Esposito, et al.
Urologic Oncology|June 6, 2026
Effect of marital status on years of life lost from metastatic bladder cancer according to sex and race/ethnicityMichele Petix, Federico Polverino, Leonardo Quarta, et al.
Pageof 100

Showing results (641-650 of 993) with videos related to

Sort By:
Pageof 100
Oncotarget|August 28, 2019
V-ATPase-associated prorenin receptor is upregulated in prostate cancer after PTEN lossAmro H Mohammad, Sarah Assadian, Frédéric Couture, et al.
World Journal of Urology|October 12, 2022
Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicityGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
Journal of Racial and Ethnic Health Disparities|January 9, 2025
Non-Caucasian Race/Ethnicity Predisposes to Unfavorable Stage and Grade at Upper Tract Urothelial Carcinoma DiagnosisFrancesco Di Bello, Mario de Angelis, Carolin Siech, et al.
Annals of Surgical Oncology|October 8, 2024
Perioperative Complications and In-Hospital Mortality in Paraplegic Radical Cystectomy PatientsFrancesco Di Bello, Carolin Siech, Mario de Angelis, et al.
Annals of Surgical Oncology|September 23, 2024
Adult Prostate Sarcoma: Demographics, Treatment Patterns, and SurvivalCarolin Siech, Mario de Angelis, Francesco Di Bello, et al.
The Journal of Urology|November 28, 2022
Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell CarcinomaGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
European Urology|July 13, 2016
Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302Johann S de Bono, Matthew R Smith, Fred Saad, et al.
The Prostate|February 17, 2015
Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North AmericaAnthony M Joshua, Neal D Shore, Fred Saad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2026
131I-LNTH-1095 Radioligand Therapy Plus Enzalutamide vs. Enzalutamide Alone in Men With PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase 2 StudyEvan Y Yu, Vivek Narayan, Giuseppe Esposito, et al.
Urologic Oncology|June 6, 2026
Effect of marital status on years of life lost from metastatic bladder cancer according to sex and race/ethnicityMichele Petix, Federico Polverino, Leonardo Quarta, et al.
Pageof 100